Sonoma Keeps You Informed

Sign up for email alerts to receive Sonoma updates including press releases, filings and special announcements straight to your inbox.

Sign me up for:

Latest Annual Filing

Fiscal Year Ended Mar 31, 2020

View Filing

Stock Information

Company Overview

Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company's products, which are sold throughout the world, have improved outcomes for more than ten million patients globally by reducing infection, itch, pain, scarring and harmful inflammatory responses. Sonoma’s headquarters are in Petaluma, California, with manufacturing operations in both the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands.

Sonoma Investor Presentation March 2021

Sonoma Investor Presentation March 2021

Download Sonoma Investor Presentation March 2021


Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information


Sonoma Pharmaceuticals, Inc.
645 Molly Lane
Suite 150
Woodstock, GA 30189

Investor Relations

T: 470-938-1011

Transfer Agent

462 South 4th Street
Suite 1600
Louisville, KY 40202
T: 888-647-8901